These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1647388)

  • 1. Antimicrobial activity of rifabutin in combination with two and three other antimicrobial agents against strains of Mycobacterium paratuberculosis.
    Chiodini RJ
    J Antimicrob Chemother; 1991 Feb; 27(2):171-6. PubMed ID: 1647388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intra-macrophagic activity of antibiotics combinations against Mycobacterium marinum].
    Gevaudan MJ; Bollet C; Mallet MN; de Micco P
    Pathol Biol (Paris); 1991 May; 39(5):436-41. PubMed ID: 1652732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal activities of various antimicrobial agents against human and animal isolates of Mycobacterium paratuberculosis.
    Chiodini RJ
    Antimicrob Agents Chemother; 1990 Feb; 34(2):366-7. PubMed ID: 2327783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bacteriostatic and bactericidal study of rifabutine and clofazimine in combination against Mycobacterium avium-intracellulare and Mycobacterium xenopi].
    Gevaudan MJ; Mallet MN; Bollet C; Gulian C; de Micco P
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):585-90. PubMed ID: 2552379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations.
    Hoffner SE; Hjelm U; Källenius G
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1285-8. PubMed ID: 8392308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in-vitro bactericidal activities of combinations of antimicrobial agents against clinical isolates of Mycobacterium avium-intracellulare.
    Kent RJ; Bakhtiar M; Shanson DC
    J Antimicrob Chemother; 1992 Nov; 30(5):643-50. PubMed ID: 1493981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi].
    Gevaudan MJ; Bollet C; Mallet MN; de Lamballerie X; Sambuc R; de Micco P
    Pathol Biol (Paris); 1992 May; 40(5):443-9. PubMed ID: 1323093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of sodium salicylate on antibiotic susceptibility and synergy in Klebsiella pneumoniae.
    Domenico P; Hopkins T; Cunha BA
    J Antimicrob Chemother; 1990 Sep; 26(3):343-51. PubMed ID: 2228825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinations of rifampin or rifabutine plus ethambutol against Mycobacterium avium complex. Bactericidal synergistic, and bacteriostatic additive or synergistic effects.
    Heifets LB; Iseman MD; Lindholm-Levy PJ
    Am Rev Respir Dis; 1988 Mar; 137(3):711-5. PubMed ID: 2830814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro synergistic activity between ofloxacin and ansamycins against Mycobacterium leprae.
    Dhople AM; Ibanez MA; Gardner GD
    Arzneimittelforschung; 1993 Mar; 43(3):384-6. PubMed ID: 8387790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy and antagonism of combinations with quinolones.
    Neu HC
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):255-61. PubMed ID: 1864285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of interactions of antibacterial drugs with each other and with 6-mercaptopurine on in vitro growth of Mycobacterium avium subspecies paratuberculosis.
    Krishnan MY; Manning EJ; Collins MT
    J Antimicrob Chemother; 2009 Nov; 64(5):1018-23. PubMed ID: 19759042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of seven antimicrobial agents, alone and in combination, against AIDS-associated isolates of Mycobacterium avium complex.
    Piersimoni C; Tortoli E; Mascellino MT; Passerini Tosi C; Sbaraglia G; Mandler F; Bistoni F; Bornigia S; De Sio G; Goglio A
    J Antimicrob Chemother; 1995 Sep; 36(3):497-502. PubMed ID: 8830013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination.
    Pryjma M; Burian J; Thompson CJ
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760147
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro activity of levofloxacin, singly and in combination with rifamycin analogs, against Mycobacterium leprae.
    Dhople AM; Ibanez MA
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2116-9. PubMed ID: 8540726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
    Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
    Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of various antibiotic combinations using the E-Test method in multiresistant Pseudomonas aeruginosa strains.
    Kocazeybek B; Arabaci U; Erentürk S; Akdur H
    Chemotherapy; 2002 Mar; 48(1):31-5. PubMed ID: 11901254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro activity of three new fluoroquinolones and synergy with ansamycins against Mycobacterium leprae.
    Dhople AM; Ibanez MA
    J Antimicrob Chemother; 1993 Sep; 32(3):445-51. PubMed ID: 8262866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial synergism against Mycobacterium avium complex strains isolated from patients with acquired immune deficiency syndrome.
    Yajko DM; Kirihara J; Sanders C; Nassos P; Hadley WK
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1392-5. PubMed ID: 3196000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
    Huang CC; Wu MF; Chen HC; Huang WC
    J Microbiol Immunol Infect; 2018 Oct; 51(5):636-643. PubMed ID: 28705770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.